<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Evaluation and treatment of hypertensive emergencies in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Evaluation and treatment of hypertensive emergencies in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Evaluation and treatment of hypertensive emergencies in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">William J Elliott, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph Varon, MD, FACP, FCCP, FCCM, FRSM</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">George L Bakris, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">William B White, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John P Forman, MD, MSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 14, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION AND TERMINOLOGY</span><span class="headingEndMark"> — </span>Most patients with significantly elevated blood pressure (systolic pressure ≥180 mmHg and/or diastolic pressure ≥120 mmHg) have no acute, end-organ injury (so called severe asymptomatic hypertension). Although some propose relatively rapid initiation of antihypertensive therapy in this setting, there may be more risk than benefit from such an aggressive regimen. (See  <a class="medical medical_review" href="/d/html/3830.html" rel="external">"Management of severe asymptomatic hypertension (hypertensive urgencies) in adults"</a>.)</p><p>By contrast, some patients with significantly elevated blood pressure have signs or symptoms of acute, ongoing target-organ damage. Such patients have a hypertensive emergency [<a href="#rid1">1</a>]. Hypertensive emergencies can develop in patients with or without known preexisting hypertension [<a href="#rid2">2,3</a>]. In younger (&lt;60 years of age) people, the diastolic pressure is typically ≥120 mmHg, but there is no specific threshold since individuals who develop an acute rise in blood pressure can develop symptoms if the previous pressure was normal (such as in a pregnant person who develops eclampsia or a young adult who develops acute glomerulonephritis).</p><p>The term "malignant hypertension" entered the medical lexicon in 1928 because, at that time, patients with this condition had a prognosis that was similar to patients with many cancers. However, antihypertensive therapies that can quickly and safely lower blood pressure have improved outcomes [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H70455669"><span class="h1">EVALUATION AND DIAGNOSIS</span><span class="headingEndMark"> — </span>The history and physical examination in patients presenting with a severely elevated blood pressure (or an acute rise in blood pressure over a previously normal baseline, even if the presenting pressure is &lt;180/120 mmHg) should determine whether any of the following are present [<a href="#rid1">1,5</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Acute head injury or trauma</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Generalized neurologic symptoms, such as agitation, delirium, stupor, seizures, or visual disturbances</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Focal neurologic symptoms that could be due to an ischemic or hemorrhagic stroke</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fresh flame hemorrhages, exudates (cotton-wool spots), or papilledema when direct funduscopy is performed, as these are consistent with grade III or IV hypertensive retinopathy and can rarely be associated with hypertensive encephalopathy</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nausea and vomiting, which may be a sign of increased intracranial pressure</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chest discomfort or pain, which may be due to myocardial ischemia or aortic dissection</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute, severe back pain, which might be due to aortic dissection</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dyspnea, which may be due to pulmonary edema</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pregnancy, as such patients with severe hypertension could have preeclampsia or develop eclampsia  (<a class="graphic graphic_table graphicRef79977" href="/d/graphic/79977.html" rel="external">table 1</a>) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use of drugs that can produce a hyperadrenergic state, such as cocaine, amphetamine(s), phencyclidine, or monoamine oxidase inhibitors, or recent discontinuation of <a class="drug drug_general" data-topicid="9285" href="/d/drug information/9285.html" rel="external">clonidine</a> or, less commonly, other antihypertensive agents</p><p></p><p>In addition, the following tests should be performed to evaluate the presence of target-organ damage in association with targeted clinical symptoms or signs:</p><p class="bulletIndent1"><span class="glyph">●</span>Electrocardiography</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Conventional chest radiography</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urinalysis, urine pregnancy test (if appropriate)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Serum electrolytes and serum creatinine</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac biomarkers (if an acute coronary syndrome is suspected)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Computed tomography (CT) or magnetic resonance imaging (MRI) of the brain (if head injury, neurologic symptoms, hypertensive retinopathy, nausea, or vomiting are present)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Contrast-enhanced CT or MRI of the chest or transesophageal echocardiography (if aortic dissection is suspected, although rapid blood pressure lowering need not be delayed in such patients while awaiting the results of imaging)</p><p></p><p>It is often easiest to categorize hypertensive emergencies by the target organ that is being damaged (eg, brain, heart, kidney). The evaluation above can usually identify the at-risk target organ and can dictate both the target blood pressure and the rapidity with which the target is achieved. (See <a class="local">'Treatment'</a> below.)</p><p>Hypertensive emergencies are uncommon, with an estimated population incidence (based upon large claims databases) of one to two cases per million per year. Various retrospective reviews from adult emergency departments found that hypertensive emergencies account for less than 1 percent of all visits [<a href="#rid6">6-9</a>]. In studies that classified hypertensive emergencies [<a href="#rid6">6,7</a>], eclampsia and aortic dissection were the least common (2 percent), whereas cerebral infarction (39 to 40 percent) and acute pulmonary edema (25 to 32 percent) were the most common, similar to the conclusions of a separate report [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H70455682"><span class="h1">TREATMENT</span></p><p class="headingAnchor" id="H454986150"><span class="h2">Overall approach to therapy</span><span class="headingEndMark"> — </span>Optimal therapy, including the choice of agent and the blood pressure goal, varies according to the specific hypertensive emergency [<a href="#rid1">1,11,12</a>].</p><p>It is generally unwise to lower the blood pressure too quickly or too much as ischemic damage can occur in vascular beds that have become habituated with the higher level of blood pressure (ie, autoregulation) [<a href="#rid13">13</a>]. For most hypertensive emergencies, mean arterial pressure should be reduced gradually by approximately 10 to 20 percent in the first hour and by a further 5 to 15 percent over the next 23 hours [<a href="#rid12">12</a>]. This often results in a target blood pressure of &lt;180/&lt;120 mmHg for the first hour and &lt;160/&lt;110 mmHg for the next 23 hours (but rarely &lt;130/&lt;80 mmHg during that time frame).</p><p>The major exceptions to gradual blood pressure lowering over the first day are:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute phase of an ischemic stroke</strong> – The blood pressure is usually <strong>not</strong> lowered unless it is ≥185/110 mmHg in patients who are candidates for reperfusion therapy  (<a class="graphic graphic_table graphicRef50725" href="/d/graphic/50725.html" rel="external">table 2</a>) or ≥220/120 mmHg in patients who are not candidates for reperfusion (thrombolytic) therapy [<a href="#rid14">14,15</a>]. (See  <a class="medical medical_review" href="/d/html/1126.html" rel="external">"Initial assessment and management of acute stroke", section on 'Blood pressure management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute aortic dissection</strong> – The systolic blood pressure should be <strong>rapidly</strong> lowered to a target of 100 to 120 mmHg (to be attained in 20 minutes) to reduce aortic shearing forces  (<a class="graphic graphic_table graphicRef111189" href="/d/graphic/111189.html" rel="external">table 3</a>) [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/d/html/8188.html" rel="external">"Management of acute type B aortic dissection", section on 'Anti-impulse therapy'</a> and  <a class="medical medical_review" href="/d/html/8178.html" rel="external">"Overview of acute aortic dissection and other acute aortic syndromes", section on 'Acute medical management'</a> and  <a class="medical medical_review" href="/d/html/120327.html" rel="external">"Management of acute type A aortic dissection", section on 'Acute management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intracerebral hemorrhage</strong> – Goals of antihypertensive therapy in such patients are variable and are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis", section on 'Blood pressure management'</a>.)</p><p></p><p>After a suitable period (often 8 to 24 hours) of blood pressure control at target in the intensive care unit, oral medications are usually given and the initial intravenous therapy is tapered and discontinued.</p><p class="headingAnchor" id="H60092188"><span class="h2">Neurologic emergencies</span><span class="headingEndMark"> — </span>Severe hypertension with acute neurologic signs or symptoms is usually the most complicated and difficult clinical scenario as the differential diagnosis includes varied conditions that have disparate treatments, only some of which routinely involve lowering the blood pressure:</p><p class="bulletIndent1"><span class="glyph">●</span>Ischemic stroke – Management of blood pressure in patients with acute ischemic stroke, including the preferred antihypertensive medications in this setting, is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/1126.html" rel="external">"Initial assessment and management of acute stroke", section on 'Blood pressure management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hemorrhagic stroke – Management of blood pressure in patients with spontaneous intracerebral hemorrhage and subarachnoid hemorrhage is complicated by competing risks (eg, reducing cerebral perfusion) and benefits (eg, reducing further bleeding) [<a href="#rid17">17</a>]. Intravenous <a class="drug drug_general" data-topicid="9540" href="/d/drug information/9540.html" rel="external">labetalol</a> and <a class="drug drug_general" data-topicid="9697" href="/d/drug information/9697.html" rel="external">nicardipine</a> are most often used as first-line agents [<a href="#rid18">18</a>], although shorter-acting drugs might be more advantageous. The management of blood pressure in patients with hemorrhagic stroke is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis", section on 'Blood pressure management'</a> and  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis", section on 'Blood pressure control'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Head trauma – Head trauma with increased intracranial pressure can produce severe elevations in blood pressure. Hypertension is usually treated in this setting only if the cerebral perfusion pressure (mean arterial pressure minus intracranial pressure) is &gt;120 mmHg and the intracranial pressure is &gt;20 mmHg. Extreme caution is recommended regarding the intensity of treatment as aggressive reductions in blood pressure are associated with worse outcomes. (See  <a class="medical medical_review" href="/d/html/1659.html" rel="external">"Evaluation and management of elevated intracranial pressure in adults", section on 'Blood pressure control'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypertensive encephalopathy – In contrast to stroke and head trauma, the signs and symptoms of hypertensive encephalopathy (eg, headache, confusion, nausea, vomiting) usually abate after the blood pressure is lowered (see  <a class="medical medical_review" href="/d/html/3833.html" rel="external">"Moderate to severe hypertensive retinopathy and hypertensive encephalopathy in adults"</a>). In fact, hypertensive encephalopathy is most often a diagnosis of exclusion, confirmed retrospectively when the mental status improves after the blood pressure is lowered into the autoregulatory range. Thus, patients with suspected hypertensive encephalopathy should have their blood pressure lowered by approximately 10 to 20 percent during the first hour of treatment. However, additional lowering should be gradual such that, compared with the initial blood pressure upon presentation, the pressure is reduced by no more than 25 percent at the end of the first day of treatment. Commonly used medications in this setting include <a class="drug drug_general" data-topicid="8911" href="/d/drug information/8911.html" rel="external">clevidipine</a>, <a class="drug drug_general" data-topicid="9697" href="/d/drug information/9697.html" rel="external">nicardipine</a>, <a class="drug drug_general" data-topicid="8629" href="/d/drug information/8629.html" rel="external">fenoldopam</a>, and <a class="drug drug_general" data-topicid="9707" href="/d/drug information/9707.html" rel="external">nitroprusside</a>.</p><p></p><p class="headingAnchor" id="H70455727"><span class="h2">Cardiac emergencies</span><span class="headingEndMark"> — </span>The most common cardiac emergencies associated with severely elevated blood pressure are acute left ventricular dysfunction with pulmonary edema and acute coronary syndrome (including acute myocardial infarction):</p><p class="bulletIndent1"><span class="glyph">●</span>Acute heart failure – Patients with acute left ventricular dysfunction and pulmonary edema should usually receive loop diuretics. A vasodilator that is easy to titrate (eg, sodium <a class="drug drug_general" data-topicid="9707" href="/d/drug information/9707.html" rel="external">nitroprusside</a>, <a class="drug drug_general" data-topicid="9706" href="/d/drug information/9706.html" rel="external">nitroglycerin</a>) is often added to reduce afterload. Drugs that increase cardiac work (eg, <a class="drug drug_general" data-topicid="8528" href="/d/drug information/8528.html" rel="external">hydralazine</a>) or acutely decrease cardiac contractility (eg, <a class="drug drug_general" data-topicid="9540" href="/d/drug information/9540.html" rel="external">labetalol</a> or other beta blocker) should be avoided [<a href="#rid19">19</a>]. The goal of these therapies is amelioration of volume excess and heart failure and improvement in pulmonary edema, which can often be achieved with a 10 to 15 percent reduction in blood pressure. (See  <a class="medical medical_review" href="/d/html/3454.html" rel="external">"Treatment of acute decompensated heart failure: General considerations"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute coronary syndrome – Severe hypertension associated with an acute coronary syndrome (including acute myocardial infarction) is appropriately treated with intravenous <a class="drug drug_general" data-topicid="9706" href="/d/drug information/9706.html" rel="external">nitroglycerin</a>, <a class="drug drug_general" data-topicid="8911" href="/d/drug information/8911.html" rel="external">clevidipine</a>, <a class="drug drug_general" data-topicid="9697" href="/d/drug information/9697.html" rel="external">nicardipine</a>, or intravenous <a class="drug drug_general" data-topicid="9645" href="/d/drug information/9645.html" rel="external">metoprolol</a> or <a class="drug drug_general" data-topicid="9420" href="/d/drug information/9420.html" rel="external">esmolol</a> (to reduce myocardial oxygen consumption, reduce the underlying coronary ischemia, and improve prognosis) [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/d/html/66.html" rel="external">"Overview of the acute management of ST-elevation myocardial infarction"</a> and  <a class="medical medical_review" href="/d/html/68.html" rel="external">"Overview of the acute management of non-ST-elevation acute coronary syndromes"</a>.)</p><p></p><p class="headingAnchor" id="H70455791"><span class="h2">Vascular emergencies</span><span class="headingEndMark"> — </span>Vascular emergencies include acute aortic dissection and severe hypertension in patients who have recently undergone vascular surgery:</p><p class="bulletIndent1"><span class="glyph">●</span>Acute aortic dissection – Patients with acute aortic dissection are treated to rapidly reduce the blood pressure to a goal systolic of 100 to 120 mmHg within approximately 20 minutes of diagnosis  (<a class="graphic graphic_table graphicRef111189" href="/d/graphic/111189.html" rel="external">table 3</a>), although this target is not based upon clinical trial evidence. An intravenous beta blocker is given first (usually <a class="drug drug_general" data-topicid="9420" href="/d/drug information/9420.html" rel="external">esmolol</a>, but <a class="drug drug_general" data-topicid="9540" href="/d/drug information/9540.html" rel="external">labetalol</a>, <a class="drug drug_general" data-topicid="9829" href="/d/drug information/9829.html" rel="external">propranolol</a>, and <a class="drug drug_general" data-topicid="9645" href="/d/drug information/9645.html" rel="external">metoprolol</a> can also be used) to reduce the heart rate below 60 beats per minute and the shear stress on the aortic wall [<a href="#rid21">21</a>]. In addition, a vasodilator (often <a class="drug drug_general" data-topicid="9707" href="/d/drug information/9707.html" rel="external">nitroprusside</a> or <a class="drug drug_general" data-topicid="8911" href="/d/drug information/8911.html" rel="external">clevidipine</a>) is typically required to quickly achieve the goal blood pressure. (See  <a class="medical medical_review" href="/d/html/8188.html" rel="external">"Management of acute type B aortic dissection", section on 'Anti-impulse therapy'</a> and  <a class="medical medical_review" href="/d/html/8178.html" rel="external">"Overview of acute aortic dissection and other acute aortic syndromes", section on 'Acute medical management'</a> and  <a class="medical medical_review" href="/d/html/120327.html" rel="external">"Management of acute type A aortic dissection", section on 'Acute management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe hypertension in patients with recent vascular surgery – Severe elevations of blood pressure can threaten suture lines, and therefore, such patients are often treated with rapidly acting intravenous antihypertensive agents in an intensive care unit setting. Although this is common practice, no controlled studies have proven the benefit of this intervention.</p><p></p><p class="headingAnchor" id="H979099480"><span class="h2">Kidney emergencies</span><span class="headingEndMark"> — </span>Severe hypertension may occasionally cause acute injury to the kidneys (acute hypertensive nephrosclerosis, formerly called "malignant nephrosclerosis"). This condition is characterized by hematuria (usually microscopic hematuria, which is found in approximately 75 percent of patients with hypertensive emergencies) [<a href="#rid22">22</a>] and an elevated serum creatinine. It is important to determine whether these findings are recent since they may predate the severe blood pressure elevation in some patients.</p><p>When kidney injury occurs as a result of severe hypertension, the common pathologic findings include fibrinoid necrosis of small arterioles and "onion skinning" of small renal arteries. The histologic changes are indistinguishable from other forms of the hemolytic uremic syndrome  (<a class="graphic graphic_picture graphicRef82156 graphicRef61658 graphicRef78330 graphicRef75317" href="/d/graphic/82156.html" rel="external">picture 1A-D</a>); however, a kidney biopsy is seldom performed in such patients. The renal vascular disease leads to glomerular ischemia and activation of the renin-angiotensin system, possibly resulting in exacerbation of the hypertension.</p><p>Antihypertensive therapy often leads to worsening kidney function; this decline in kidney function may be worse in patients with high-grade ostial stenosis of one or both renal arteries. Although this acute kidney injury sometimes requires dialysis, the reduction in kidney function may be reversed with long-term blood pressure control [<a href="#rid23">23</a>]. By contrast, <a class="drug drug_general" data-topicid="8629" href="/d/drug information/8629.html" rel="external">fenoldopam</a> is associated with a temporary improvement in kidney function and is therefore a useful antihypertensive agent in patients with kidney hypertensive emergencies [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/d/html/3840.html" rel="external">"Drugs used for the treatment of hypertensive emergencies"</a>.)</p><p class="headingAnchor" id="H501883273"><span class="h2">Sympathetic overactivity resulting in hypertensive emergencies</span><span class="headingEndMark"> — </span>Four causes of sympathetic overactivity can lead to severe elevations of blood pressure and acute target-organ damage:</p><p class="bulletIndent1"><span class="glyph">●</span>Withdrawal of short-acting antihypertensive agents (especially <a class="drug drug_general" data-topicid="9285" href="/d/drug information/9285.html" rel="external">clonidine</a>, <a class="drug drug_general" data-topicid="9829" href="/d/drug information/9829.html" rel="external">propranolol</a>, or other beta blockers) can be associated with severe hypertension and may mimic the signs and symptoms of pheochromocytoma. Typically, reinstitution of the recently discontinued drug will lower the blood pressure. Oral clonidine will begin to lower blood pressure within an hour; however, some beta blockers take much longer to lower the blood pressure and, therefore, short-acting intravenous medications are often required while waiting for the reinstituted beta blocker to achieve an effect. (See  <a class="medical medical_review" href="/d/html/3864.html" rel="external">"Tapering and discontinuing antihypertensive medications"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ingestion of sympathomimetic agents (eg, tyramine-containing foods in patients who take chronic monoamine oxidase inhibitors [<a href="#rid11">11</a>], amphetamine-like compounds, cocaine, etc) can precipitate severe hypertension and end-organ damage. Such patients can be treated with intravenous <a class="drug drug_general" data-topicid="9767" href="/d/drug information/9767.html" rel="external">phentolamine</a> or, if phentolamine is unavailable, <a class="drug drug_general" data-topicid="9707" href="/d/drug information/9707.html" rel="external">nitroprusside</a> [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/d/html/4953.html" rel="external">"Clinical manifestations, diagnosis, and management of the cardiovascular complications of cocaine abuse"</a> and  <a class="medical medical_review" href="/d/html/303.html" rel="external">"Cocaine: Acute intoxication"</a> and  <a class="medical medical_review" href="/d/html/311.html" rel="external">"Methamphetamine: Acute intoxication"</a> and  <a class="medical medical_review" href="/d/html/82952.html" rel="external">"Acute amphetamine and synthetic cathinone ("bath salt") intoxication"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pheochromocytoma can also produce severe hypertension and acute target-organ damage. The treatment of hypertension in pheochromocytoma is discussed separately. (See  <a class="medical medical_review" href="/d/html/142.html" rel="external">"Treatment of pheochromocytoma in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe autonomic dysfunction (eg, Guillain-Barré and multiple system atrophy syndromes or acute spinal cord injury) is occasionally associated with hypertensive emergency. Such patients can be treated with <a class="drug drug_general" data-topicid="9767" href="/d/drug information/9767.html" rel="external">phentolamine</a>, <a class="drug drug_general" data-topicid="9707" href="/d/drug information/9707.html" rel="external">nitroprusside</a>, <a class="drug drug_general" data-topicid="9540" href="/d/drug information/9540.html" rel="external">labetalol</a>, or other agents. (See  <a class="medical medical_review" href="/d/html/4839.html" rel="external">"Chronic complications of spinal cord injury and disease", section on 'Cardiovascular complications'</a> and  <a class="medical medical_review" href="/d/html/5172.html" rel="external">"Guillain-Barré syndrome in adults: Treatment and prognosis", section on 'Cardiovascular and autonomic status'</a>.)</p><p></p><p>Unless a beta blocker was recently withdrawn, administration of a beta blocker alone is <strong>contraindicated</strong> in these settings since inhibition of beta receptor-induced vasodilation can result in unopposed alpha-adrenergic vasoconstriction and a further rise in blood pressure [<a href="#rid26">26</a>]. (See  <a class="medical medical_review" href="/d/html/130.html" rel="external">"Clinical presentation and diagnosis of pheochromocytoma"</a>.)</p><p class="headingAnchor" id="H501883319"><span class="h2">Hypertensive emergencies during pregnancy</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="8528" href="/d/drug information/8528.html" rel="external">Hydralazine</a> and <a class="drug drug_general" data-topicid="9540" href="/d/drug information/9540.html" rel="external">labetalol</a> have been widely used in pregnant people with severe hypertension, which is usually due to preeclampsia or exacerbation of preexistent hypertension. <a class="drug drug_general" data-topicid="8629" href="/d/drug information/8629.html" rel="external">Fenoldopam</a> and <a class="drug drug_general" data-topicid="9697" href="/d/drug information/9697.html" rel="external">nicardipine</a> have also been used.</p><p>These issues as well as antihypertensive drugs that are contraindicated in pregnancy are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/6815.html" rel="external">"Treatment of hypertension in pregnant and postpartum patients", section on 'Acute therapy of severe hypertension'</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ANTIHYPERTENSIVE DRUGS</span><span class="headingEndMark"> — </span>An overview of the mechanism of action, doses, and routes of administration of many antihypertensive drugs that are often used for hypertensive emergency is presented elsewhere. (See  <a class="medical medical_review" href="/d/html/3840.html" rel="external">"Drugs used for the treatment of hypertensive emergencies"</a>.)</p><p class="headingAnchor" id="H352186959"><span class="h1">FOLLOW-UP</span><span class="headingEndMark"> — </span>Secondary causes of hypertension are more common in patients who have a hypertensive emergency compared with other hypertensive populations [<a href="#rid27">27</a>]. Thus, patients with a hypertensive emergency should be evaluated for common forms of secondary hypertension and, if there are suggestive clinical clues, less common causes of secondary hypertension. Patients should be reminded that adherence to long-term antihypertensive drug therapy can reduce the risk of recurrent hospitalization for hypertensive emergencies.</p><p>The most important aspect of care for the patient with a hypertensive emergency is assuring that high-quality outpatient follow-up is available as many of the presenting problems (including dialysis for end-stage kidney disease) can improve greatly if the blood pressure is well controlled in the long term. A large proportion of patients without follow-up will return to the hospital with a repeated hypertensive emergency [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H1513648914"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/109601.html" rel="external">"Society guideline links: Hypertension in adults"</a>.)</p><p class="headingAnchor" id="H162622291"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics links (see  <a class="medical medical_basics" href="/d/html/17188.html" rel="external">"Patient education: High blood pressure emergencies (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H23657850"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Most patients with significantly elevated blood pressure (systolic pressure ≥180 mmHg and/or diastolic pressure ≥120 mmHg) have no acute, end-organ injury (so called severe asymptomatic hypertension). However, some patients with significantly elevated blood pressure have signs or symptoms of acute, ongoing target-organ damage. Such patients have a hypertensive emergency. (See <a class="local">'Introduction and terminology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – The history and physical examination in patients presenting with a severely elevated blood pressure (or an acute rise in blood pressure over a previously normal baseline, even if the presenting pressure is &lt;180/120 mmHg) should seek to identify signs and symptoms of acute target-organ damage; in addition, certain laboratory and, in some settings, imaging studies may be needed. (See <a class="local">'Evaluation and diagnosis'</a> above.)</p><p></p><p class="bulletIndent1">Common findings that raise concern for acute target organ damage include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute head injury or trauma</p><p class="bulletIndent2"><span class="glyph">•</span>Generalized neurologic symptoms (eg, agitation, delirium, seizures, visual disturbances)</p><p class="bulletIndent2"><span class="glyph">•</span>Focal neurologic symptoms </p><p class="bulletIndent2"><span class="glyph">•</span>Fresh flame hemorrhages, exudates (cotton-wool spots), or papilledema</p><p class="bulletIndent2"><span class="glyph">•</span>Nausea and vomiting</p><p class="bulletIndent2"><span class="glyph">•</span>Chest discomfort or pain</p><p class="bulletIndent2"><span class="glyph">•</span>Acute, severe back pain</p><p class="bulletIndent2"><span class="glyph">•</span>Dyspnea</p><p class="bulletIndent2"><span class="glyph">•</span>Pregnancy</p><p class="bulletIndent2"><span class="glyph">•</span>Use of drugs that can produce a hyperadrenergic state</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute management</strong> – Optimal therapy, including the choice of agent and the blood pressure goal, varies according to the specific hypertensive emergency. It is generally unwise to lower the blood pressure too quickly or too much, as ischemic damage can occur in vascular beds that have reset their autoregulatory threshold to the higher level of blood pressure. For most hypertensive emergencies, mean arterial pressure should be reduced by approximately 10 to 20 percent in the first hour and then gradually during the next 23 hours so that the final pressure is reduced by approximately 25 percent compared with baseline. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent1">The major exceptions to modest and gradual blood pressure lowering over the first 24 hours are:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute phase of an ischemic stroke – The blood pressure is usually <strong>not</strong> lowered unless it is ≥185/110 mmHg in patients who are candidates for reperfusion therapy  (<a class="graphic graphic_table graphicRef50725" href="/d/graphic/50725.html" rel="external">table 2</a>) or ≥220/120 mmHg in patients who are not candidates for reperfusion therapy. (See  <a class="medical medical_review" href="/d/html/1126.html" rel="external">"Initial assessment and management of acute stroke", section on 'Blood pressure management'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute aortic dissection – The systolic blood pressure is <strong>rapidly</strong> lowered to a target of 100 to 120 mmHg (to be attained in 20 minutes). (See  <a class="medical medical_review" href="/d/html/8188.html" rel="external">"Management of acute type B aortic dissection", section on 'Anti-impulse therapy'</a> and  <a class="medical medical_review" href="/d/html/8178.html" rel="external">"Overview of acute aortic dissection and other acute aortic syndromes", section on 'Acute medical management'</a> and  <a class="medical medical_review" href="/d/html/120327.html" rel="external">"Management of acute type A aortic dissection", section on 'Acute management'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Spontaneous hemorrhagic stroke – The systolic blood pressure can be rapidly reduced if no contraindications exist. Therapy in such patients is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis", section on 'Blood pressure management'</a>.)</p><p></p><p class="bulletIndent1">A variety of intravenous (IV) antihypertensive drugs can be used to treat hypertensive emergencies; an overview of the mechanism of action, doses, and routes of administration of these agents is presented elsewhere. (See  <a class="medical medical_review" href="/d/html/3840.html" rel="external">"Drugs used for the treatment of hypertensive emergencies"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postacute management</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Conversion from IV to oral therapy – After a suitable period (often 8 to 24 hours) of blood pressure control at target in an intensive care unit, oral medications are usually given and the initial intravenous therapy is tapered and discontinued. (See <a class="local">'Overall approach to therapy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Secondary causes of hypertension are more common in patients who have a hypertensive emergency compared with other hypertensive populations. Thus, patients with a hypertensive emergency should be evaluated for common forms of secondary hypertension and, if there are suggestive clinical clues, less common causes of secondary hypertension. (See <a class="local">'Follow-up'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The most important aspect of care for the patient with a hypertensive emergency is assuring that high-quality outpatient follow-up is available. A large proportion of patients without follow-up will return to the hospital with a recurrent hypertensive emergency. (See <a class="local">'Follow-up'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Peixoto AJ. Acute Severe Hypertension. N Engl J Med 2019; 381:1843.</a></li><li><a class="nounderline abstract_t">Mayer SA, Kurtz P, Wyman A, et al. Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension registry. Crit Care Med 2011; 39:2330.</a></li><li><a class="nounderline abstract_t">Padilla Ramos A, Varon J. Current and newer agents for hypertensive emergencies. Curr Hypertens Rep 2014; 16:450.</a></li><li><a class="nounderline abstract_t">Katz JN, Gore JM, Amin A, et al. Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. Am Heart J 2009; 158:599.</a></li><li><a class="nounderline abstract_t">Johnson W, Nguyen ML, Patel R. Hypertension crisis in the emergency department. Cardiol Clin 2012; 30:533.</a></li><li><a class="nounderline abstract_t">Astarita A, Covella M, Vallelonga F, et al. Hypertensive emergencies and urgencies in emergency departments: a systematic review and meta-analysis. J Hypertens 2020; 38:1203.</a></li><li><a class="nounderline abstract_t">Martin JF, Higashiama E, Garcia E, et al. Hypertensive crisis profile. Prevalence and clinical presentation. Arq Bras Cardiol 2004; 83:131.</a></li><li><a class="nounderline abstract_t">Salvetti M, Paini A, Colonetti E, et al. Hypertensive emergencies and urgencies: a single-centre experience in Northern Italy 2008-2015. J Hypertens 2020; 38:52.</a></li><li><a class="nounderline abstract_t">Paini A, Tarozzi L, Bertacchini F, et al. Cardiovascular prognosis in patients admitted to an emergency department with hypertensive emergencies and urgencies. J Hypertens 2021; 39:2514.</a></li><li><a class="nounderline abstract_t">Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension 1996; 27:144.</a></li><li class="breakAll">Kaplan NM, Victor RG. Chapter 8: Hypertensive Emergencies. In: Kaplan's Clinical Hypertension, 11th Ed, Lippincott, Williams &amp; Wilkins, 2014. p.263.</li><li><a class="nounderline abstract_t">Elliott WJ. Clinical features in the management of selected hypertensive emergencies. Prog Cardiovasc Dis 2006; 48:316.</a></li><li><a class="nounderline abstract_t">Alshami A, Romero C, Avila A, Varon J. Management of hypertensive crises in the elderly. J Geriatr Cardiol 2018; 15:504.</a></li><li><a class="nounderline abstract_t">Ahmed N, Wahlgren N, Brainin M, et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). Stroke 2009; 40:2442.</a></li><li><a class="nounderline abstract_t">Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44:870.</a></li><li><a class="nounderline abstract_t">Li JZ, Eagle KA, Vaishnava P. Hypertensive and acute aortic syndromes. Cardiol Clin 2013; 31:493.</a></li><li><a class="nounderline abstract_t">Anderson CS, Selim MH, Molina CA, Qureshi AI. Intensive Blood Pressure Lowering in Intracerebral Hemorrhage. Stroke 2017; 48:2034.</a></li><li><a class="nounderline abstract_t">Peacock WF 4th, Hilleman DE, Levy PD, et al. A systematic review of nicardipine vs labetalol for the management of hypertensive crises. Am J Emerg Med 2012; 30:981.</a></li><li><a class="nounderline abstract_t">Alexander P, Alkhawam L, Curry J, et al. Lack of evidence for intravenous vasodilators in ED patients with acute heart failure: a systematic review. Am J Emerg Med 2015; 33:133.</a></li><li><a class="nounderline abstract_t">Lau J, Antman EM, Jimenez-Silva J, et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992; 327:248.</a></li><li><a class="nounderline abstract_t">Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121:e266.</a></li><li><a class="nounderline abstract_t">Elliott WJ, Weber RR, Nelson KS, et al. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation 1990; 81:970.</a></li><li><a class="nounderline abstract_t">González R, Morales E, Segura J, et al. Long-term renal survival in malignant hypertension. Nephrol Dial Transplant 2010; 25:3266.</a></li><li><a class="nounderline abstract_t">Gillies MA, Kakar V, Parker RJ, et al. Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis. Crit Care 2015; 19:449.</a></li><li><a class="nounderline abstract_t">Abrams JH, Schulman P, White WB. Successful treatment of a monoamine oxidase inhibitor-tyramine hypertensive emergency with intravenous labetalol. N Engl J Med 1985; 313:52.</a></li><li><a class="nounderline abstract_t">Brown H, Goldberg PA, Selter JG, et al. Hemorrhagic pheochromocytoma associated with systemic corticosteroid therapy and presenting as myocardial infarction with severe hypertension. J Clin Endocrinol Metab 2005; 90:563.</a></li><li><a class="nounderline abstract_t">Börgel J, Springer S, Ghafoor J, et al. Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence. Clin Res Cardiol 2010; 99:499.</a></li></ol></div><div id="topicVersionRevision">Topic 3837 Version 48.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31693807" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Acute Severe Hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21666448" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24863753" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Current and newer agents for hypertensive emergencies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19781420" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23102030" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Hypertension crisis in the emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32510905" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Hypertensive emergencies and urgencies in emergency departments: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15322655" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Hypertensive crisis profile. Prevalence and clinical presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31415308" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Hypertensive emergencies and urgencies: a single-centre experience in Northern Italy 2008-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34420015" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Cardiovascular prognosis in patients admitted to an emergency department with hypertensive emergencies and urgencies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8591878" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Hypertensive urgencies and emergencies. Prevalence and clinical presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8591878" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Hypertensive urgencies and emergencies. Prevalence and clinical presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16627047" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Clinical features in the management of selected hypertensive emergencies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30364798" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Management of hypertensive crises in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19461022" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23370205" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24188216" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Hypertensive and acute aortic syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28626061" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Intensive Blood Pressure Lowering in Intracerebral Hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21908132" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : A systematic review of nicardipine vs labetalol for the management of hypertensive crises.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25530194" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Lack of evidence for intravenous vasodilators in ED patients with acute heart failure: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1614465" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Cumulative meta-analysis of therapeutic trials for myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20233780" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1968368" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20299339" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Long-term renal survival in malignant hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26703329" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4000229" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Successful treatment of a monoamine oxidase inhibitor-tyramine hypertensive emergency with intravenous labetalol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15509646" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Hemorrhagic pheochromocytoma associated with systemic corticosteroid therapy and presenting as myocardial infarction with severe hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20361196" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
